Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk disease

Overview of attention for article published in Journal of Hematology & Oncology, August 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

blogs: 1 blog
twitter: 22 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 20 Mendeley

Summary Blogs X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

ASOCIACIÓN COSTARRICENSE DE HEMATOLOGÍA- ACH, 19 Sep 2022

"Here, we review the most recent advances in therapeutic approaches in MDS, focusing on higher-risk disease. Allogeneic…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.